These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3908219)

  • 1. [Study of the process of promutagen biotransformation by the Ames test. I. The role of conjugation with glutathione in the modification of the mutagenic activity of nitrosomorpholine, diethylnitrosamine and cyclophosphamide].
    Fonshteĭn LM; Loknitskaia NN; Rotenberg IuS
    Genetika; 1985 Nov; 21(11):1821-7. PubMed ID: 3908219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The process of promutagen biotransformation studied by the Ames test. II. The extent of the manifestation of the mutagenic action of nitrosomorpholine, diethylnitrosamine and cyclophosphane using various subfractions of rat liver homogenate].
    Loknitskaia NN; Fonshteĭn LM
    Genetika; 1985 Dec; 21(12):1932-6. PubMed ID: 4085789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Study of promutagen biotransformation in the Ames test. III. The role of conjugation with glucuronic acid and sulfate in the modification of mutagenic effect of nitrosomorpholine, diethylnitrosamine and cyclophosphamide].
    Loknitskaia NN; Rotenberg IuS; Fonshteĭn LM; Shuliakovskaia TS
    Genetika; 1986 Sep; 22(9):2259-64. PubMed ID: 3533722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Butylhydroxytoluene inhibition of the mutagenic activity of carcinogenic nitroso compounds and cyclophosphamide: the role of the glutathione conjugation reaction].
    Kalinina EV; Loknitskaia NN; Shuliakovskaia TS; Fonshteĭn LM
    Vopr Onkol; 1987; 33(9):59-63. PubMed ID: 3310399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Study of promutagen biotransformation in the Ames test. IV. The effect of transplanted tumors on the biotransformation of various antineoplastic agents].
    Oblapenko NG; Loknitskaia NN; Presnova ZhF; Chernov VA; Fonshteĭn LM
    Genetika; 1986 Sep; 22(9):2265-71. PubMed ID: 3533723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study of the biotransformation of various antineoplastic agents using the Ames test].
    Oblapenko NG; Prikhod'ko AZ; Fonshteĭn LM; Chernov VA
    Eksp Onkol; 1988; 10(5):52-5. PubMed ID: 3061779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Modifying action of drug preparations on the effect of promutagen compounds].
    Oblapenko NG; Fonshteĭn LM
    Tsitol Genet; 1987; 21(2):118-22. PubMed ID: 3296365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Additional pathway of the metabolic activation of N-nitrosodiethylamine in the rat liver].
    Khripach LV; Shuliakovskaia TS; Loknitskaia NN; Fonshteĭn LM
    Eksp Onkol; 1987; 9(2):46-9. PubMed ID: 3582239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The role of UDP glucuronosyl- and sulfotransferases in the butylhydroxytoluene suppression of the mutagenic action of carcinogenic nitroso compounds and cyclophosphane].
    Kalinina EV; Loknitskaia NN; Shuliakovskaia TS; Fonshteĭn LM
    Vopr Onkol; 1989; 35(2):220-5. PubMed ID: 2494809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modification of the mutagenicity and teratogenicity of cyclophosphamide in rats with inducers of the cytochromes P-450.
    Hales BF
    Teratology; 1981 Aug; 24(1):1-11. PubMed ID: 7029774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the metabolizing capacity of S9 liver preparations from rats and mice using a test with Salmonella typhimurium TA100.
    Gajcy H; Pieńkowska K; Koziorowska J; Czarnomska A
    Pol J Pharmacol Pharm; 1987; 39(1):27-32. PubMed ID: 3313326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salmonella/human S9 mutagenicity test: a collaborative study with 58 compounds.
    Hakura A; Shimada H; Nakajima M; Sui H; Kitamoto S; Suzuki S; Satoh T
    Mutagenesis; 2005 May; 20(3):217-28. PubMed ID: 15843387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of nitrosamines and other carcinogens by mouse-liver S9, mouse hepatocytes and in the host-mediated assay produces different mutagenic responses in Salmonella TA1535.
    Kerklaan P; Bouter S; Mohn G
    Mutat Res; 1983; 110(1):9-22. PubMed ID: 6865998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Ames test study of the effect of 2nd-phase biotransformation reactions on the level of mutagenic action of a number of chemical compounds].
    Loknitskaia NN; Fonshteĭn LM
    Tsitol Genet; 1988; 22(3):43-6. PubMed ID: 3142125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of modifiers of the cytochrome P-450-dependent enzyme system of the liver on the metabolic pathways of diethylnitrosamine activation and inactivation].
    Shuliakovskaia TS; Koen IaM; Rykova VA; Loknitskaia NN; Fonshteĭn LM
    Vopr Onkol; 1987; 33(1):78-83. PubMed ID: 3544492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relative mutagenicity of some urinary metabolites of the antitumor drug cyclophosphamide.
    Balbinder E; Reich CI; Shugarts D; Keogh J; Fibiger R; Jones T; Banks A
    Cancer Res; 1981 Jul; 41(7):2967-72. PubMed ID: 7018675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutagenicity of N-nitrosodiethylamine in the Ames test with S. typhimurium TA1535 is due to volatile metabolites and is not dependent on cytochrome P4502E1 induction.
    Westphal GA; Bünger J; Schulz TG; Müller MM; Hallier E
    Arch Toxicol; 2000 Dec; 74(10):638-41. PubMed ID: 11201672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [In vivo studies on the transformation of cyclophosphamide to mutagenic metabolites].
    Della Morte R; Belisario MA; Farina C; Martire G; Staiano N; De Lorenzo F
    Boll Soc Ital Biol Sper; 1982 Aug; 58(16):1061-7. PubMed ID: 7138675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study of metabolic activation of chemical compounds by using microorganisms. I. Effect of inducers of microsomal systems].
    Fonshtein LM; Abilev SK; Akin'shina LP
    Genetika; 1978 Sep; 14(9):1564-70. PubMed ID: 363517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of cyclophosphamide mutagenicity by beta-carotene.
    Belisario MA; Pecce R; Battista C; Panza N; Pacilio G
    Biomed Pharmacother; 1985; 39(8):445-8. PubMed ID: 3914914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.